EARLY TREATMENT WITH TERLIPRESSIN AND ALBUMIN IS EFFECTIVE FOR TYPE-1 HEPATORENAL SYNDROME ASSOCIATED WITH SEPSIS

被引：0
|
作者：
Rodriguez, E. [1 ,2 ]
Elia, C. [1 ,2 ]
Sola, E. [1 ,2 ]
Barreto, R. [1 ,2 ]
Graupera, I. [1 ,2 ]
Andrealli, A. [3 ]
Pereira, G. H. [1 ,2 ]
Ariza, X. [1 ,2 ]
Poca, M. [4 ]
Sanchez, J. [5 ]
Guevara, M. [1 ,2 ]
Soriano, G. [4 ]
Alessandria, C. [3 ]
Fernandez, J. [1 ,2 ]
Arroyo, V. [1 ,2 ]
Gines, P. [1 ,2 ]
机构：
[1] Hosp Clin Barcelona, Liver Unit, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain
[2] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain
[3] Univ Turin, Osped San Giovanni Battista, Turin, Italy
[4] Hosp Santa Creu & Sant Pau, Liver Unit, Barcelona, Spain
[5] Hosp Parc Tauli, Sabadell, Spain
来源：
JOURNAL OF HEPATOLOGY | 2014年 / 60卷 / 01期
关键词：
D O I：
10.1016/S0168-8278(14)61098-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P937
引用
收藏
页码：S387 / S387
页数：1
相关论文
共 50 条
  • [1] Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis
    Rodriguez, Ezequiel
    Elia, Chiara
    Sola, Elsa
    Barreto, Rogelio
    Graupera, Isabel
    Andrealli, Alida
    Pereira, Gustavo
    Poca, Maria
    Sanchez, Jordi
    Guevara, Monica
    Soriano, German
    Alessandria, Carlo
    Fernandez, Javier
    Arroyo, Vicente
    Gines, Pere
    JOURNAL OF HEPATOLOGY, 2014, 60 (05) : 955 - 961
  • [2] Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis (vol 60, pg 955, 2014)
    Rodriguez, Ezequiel
    Elia, Chiara
    Sola, Elsa
    Barreto, Rogelio
    Graupera, Isabel
    Andrealli, Alida
    Pereira, Gustavo
    Poca, Maria
    Sanchez, Jordi
    Guevara, Monica
    Soriano, German
    Alessandria, Carlo
    Fernandez, Javier
    Arroyo, Vicente
    Gines, Pere
    JOURNAL OF HEPATOLOGY, 2014, 61 (02)
  • [3] Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome
    Wong, F.
    Pappas, S. C.
    Curry, M. P.
    Reddy, K. R.
    Rubin, R. A.
    Porayko, M. K.
    Gonzalez, S. A.
    Mumtaz, K.
    Lim, N.
    Simonetto, D. A.
    Sharma, P.
    Sanyal, A. J.
    Mayo, M. J.
    Frederick, R. T.
    Escalante, S.
    Jamil, K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (09): : 818 - 828
  • [4] Hepatorenal syndrome treatment with terlipressin and albumin
    Hamilton M.
    Critical Care, 2 (1):
  • [5] Transient increase in urine protein excretion during treatment with terlipressin and albumin for type-1 hepatorenal syndrome
    Elia, Chiara
    Sola Verges, Elsa
    Rodriguez, Ezequiel
    Gines, Pere
    JOURNAL OF HEPATOLOGY, 2015, 62 (02) : 493 - 495
  • [6] Terlipressin and albumin in cirrhotic patients with hepatorenal syndrome type-1 with and without active infection
    Serrano-Romero, M.
    Pascasio, J. M.
    Sousa, J. M.
    Cayuela, A.
    Ferrer, M. T.
    Gomez-Navarro, E.
    Prieto, J. L.
    Sayago, M.
    Cabanillas, M.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S123 - S124
  • [7] Effectiveness of Terlipressin and Albumin for the Treatment of Hepatorenal Syndrome
    Nowsherwan
    Ali, Amjad
    Ali, Anwar
    Muhammad, Atta
    Khan, Mohammad Khalid
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2021, 15 (02): : 809 - 811
  • [8] Terlipressin and albumin combination treatment in patients with hepatorenal syndrome type 2
    Marc Nguyen-Tat
    Jaeger, Julia
    Rey, Johannes Wilhelm
    Nagel, Michael
    Labenz, Christian
    Woerns, Marcus-Alexander
    Galle, Peter Robert
    Marquardt, Jens Uwe
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2019, 7 (04) : 529 - 537
  • [9] Terlipressin and albumin for the hepatorenal syndrome
    Antoniades, C
    Auzinger, G
    HEPATOLOGY, 2003, 37 (04) : 946 - 946
  • [10] Terlipressin for Type 1 Hepatorenal Syndrome
    Terbah, R.
    Gow, P.
    Sinclair, M.
    Testro, A.
    DIGESTIVE DISEASES AND SCIENCES, 2020, 65 (08) : 2454 - 2455
12345